Maze Therapeutics, Inc. (MAZE)
40.32
+1.37
(+3.52%)
USD |
NASDAQ |
Jan 09, 16:00
39.52
-0.80
(-1.98%)
After-Hours: 20:00
Maze Therapeutics Accounts Payable (Quarterly): 2.918M for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| CDT Equity, Inc. | 0.613M |
| LENZ Therapeutics, Inc. | 4.323M |
| Liminatus Pharma, Inc. | 0.5592M |
| Oruka Therapeutics, Inc. | 2.208M |
| MapLight Therapeutics, Inc. | 0.00 |